Treatment of Lung Cancer
Early Treatment with Lorlatinib Helps in Improving Lung Cancer Survival Rate
Non-small cell lung cancer accounts for 87% of all lung cancer cases and some 5% of NSCLC cases are ALK-positive. This implies that they have genetic [...]
Post-Surgical Lung Cancer Treatments
Surgery is the treatment option for patients with non-small cell lung cancer. It might be the best option as it provides high chances of curing the disease. [...]
Proton Therapy for Lung Cancer May Help Prevent Heart Disease
Proton therapy for lung cancer treatment is a reasonable treatment for patients whose cancer is limited to the chest. The physicians are able to deliver highly [...]
Moffitt Researchers Develop Tool to Predict Lung Cancer Treatment
Choosing the right therapy for non-small cell lung cancer patient is not always an easy decision. Biomarkers can change during the therapy, making that [...]
New Study Identifies Drug to Boost Lung Cancer Survival Rates
A new study has found that a newly approved drug for leading form of cancer, lung cancer works to improve patient survival rate. The immunotherapy drug is [...]
Health Benefits of Fennel for Lung Cancer Patients
Lung Cancer is a serious health problem having no respect for age and sex and can affect any person at any interval of time. Various ayurvedic herbs help lung [...]
Korean Study Examined Three-Drug Combo to Reduce Lung Cancer Risk
The combined use of aspirin, statins and metformin is associated with reduced risk of lung cancer, according to a study published in the Journal of Thoracic [...]
Non-Smoking Lung Cancer Patients May Respond Differently to Treatment
Although smoking remains the main cause of lung cancer for most of the patients but there are other factors as well which may cause lung cancer. Non-smokers [...]
Ramucirumab Injection in Combination with Erlotinib Gets FDA Approval for NSCLC
The Food and Drug Administration (FDA) has approved a 10mg/mL solution for first-line treatment of patients with metastatic non-small cell lung cancer (NSCLC) [...]
FDA Approves Tabrecta, First Targeted Therapy for NSCLC
The FDA has approved Tabrecta, Novartis for the treatment of non-small cell lung cancer (NSCLC) that has spread to other parts of the body. NSCLC is the most [...]
Tackling Coronavirus during Lung Cancer Treatment
At the end of year 2019, a novel coronavirus was identified in Wuhan, a city in the Hubei Province of China. It spread rapidly and resulted in an increasing [...]
What to Consider Before Getting A Lung Cancer on Marijuana Medication?
Lung cancer is one of the major causes of death, particularly in the US. It has been found that more people die because of it as compared to other types of [...]
Yale Cancer Center Study Shows Long-Term Survival Benefits for Lung Cancer Patients
As per the global study led by Yale Cancer Center, a tiny amount of biomarker known as PD-L1 can predict long-term survival benefits from pembrolizumab. [...]
Obesity May Boost Effectiveness of Lung Cancer Treatment, According to Study
The latest study in the field of lung cancer has revealed that an immune system-based treatment for lung cancer, worked better in people who were overweight in [...]